You can buy or sell HEPA and other stocks, options, ETFs, and crypto commission-free!
Hepion Pharmaceuticals, Inc. engages in the development and commercialization of pleiotropic drug therapy for the treatment of chronic liver disease. It focuses on the development of its product candidate CRV431, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. Read More The company was founded on May 15, 2013 and is headquartered in Edison, NJ.
Edison, New Jersey
52 Week High
52 Week Low
Expected Nov 14, After Hours